companydata.dkHemab ApS: Financial statements 2025
CVR: 40837590
Hemab ApS (CVR 40837590) has filed annual accounts for 2025. Equity amounted to DKK 196,000. The company had 54 employees in the financial year.
- Equity
- 196,000 kr.
- Employees
- 54
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | - | 196 t. | 54 |
| 2024 | - | - | - | 104 t. | 36 |
| 2023 | - | - | -22.8 mio. | 136.2 mio. | 21 |
| 2022 | - | - | -156.4 mio. | 6.1 mio. | 10 |
| 2021 | - | - | -35.2 mio. | 68 mio. | 3 |
Find more companies like Hemab ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of October 23, 2025, Joseph Anderson has joined the board of directors of Hemab ApS.
As of October 23, 2025, Mårten Steen has left the board of directors of Hemab ApS.
Hemab ApS has published its annual report for 2024.
About Hemab ApS
Hemab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Ebumab Hemophilia ApS. The management consists of Benny Sørensen and Mads Nikolaj Behrndt-Eriksen. The company is owned by Hemab Therapeutics Holdings, Inc.. Equity amounted to DKK 196,000.